ABILITY Diabetes Global enrolls thousandth patient: A Cardinal Milestone Achieved

ABILITY Diabetes Global (Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellitus Global) started off with the index patient enrolment on 11th June 2020 in Italy (at the peak of the 1st wave of COVID-19 pandemic) by P.I. Prof. Antonio Colombo and the pace of enrolment since then has been steady and consistent, with […]

thaipr.net

10 ก.ย. 64

New Global Study Supports Healthy Buildings as a Critical Public Health Strategy

Study substantiates prior findings that improved indoor air quality leads to enhanced cognitive function and health of building occupants  For the first time on a global scale, new research has found that healthy buildings with enhanced ventilation can improve the cognitive function and health of occupants, suggesting that ventilation and filtration are preeminent healthy building […]

thaipr.net

10 ก.ย. 64

DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants

DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can now be commercialized within the EU and the rest of the world. This new multiplex qPCR-based test screens for the SARS-CoV-2 […]

thaipr.net

10 ก.ย. 64

RedHill Biopharma’s Opaganib Demonstrates Significant Decrease of Kidney Fibrosis

– COVID-19 and long COVID patients are at increased risk of developing kidney damage – Opaganib significantly decreased kidney fibrosis in a preclinical in vivo model – Renal fibrosis is a progressive process which occurs in patients with chronic kidney disease (CKD) and can ultimately lead to end-stage renal failure – Opaganib is a novel, late clinical-stage oral pill […]

thaipr.net

10 ก.ย. 64

Gan & Lee Pharmaceuticals to present recent data at the 57th Annual European Association for the Study of Diabetes Meeting

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is excited to present positive data from five recent abstracts which will be featured as short oral discussions at the 57th Annual European Association for the Study of Diabetes (EASD) Meeting. The meeting will be held virtually from September 27th – […]

thaipr.net

9 ก.ย. 64

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

— First participants enrolled in Phase 1 clinical trial of combination NanoFlu™/NVX–CoV2373 vaccine with Matrix-M™ adjuvant — Phase 1/2 study will evaluate immunogenicity and safety Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in a Phase 1/2 study to evaluate […]

thaipr.net

9 ก.ย. 64

RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021

– Two new analyses of Movantik® (naloxegol) data evaluated the safety and efficacy of Movantik in a subgroup of patients aged ≥ 65 years – Analysis of Movantik effects on rapid and sustained improvement of both spontaneous and complete spontaneous bowel movements in the Movantik group vs. placebo were evaluated across high and low opioid dosages – Movantik is the U.S. […]

thaipr.net

9 ก.ย. 64

Yiling Pharmaceutical’s Yishen Yangxin Anshen Tablets Granted Drug Certificate

Yiling Pharmaceutical recently announced that its newly-developed drug Yishen Yangxin Anshen Tablet had been granted official drug certificate by China’s National Medical Products Administration (NMPA). With the functions of reinforcing kidney, nourishing heart, and tranquilizing mind, this drug offers a new treatment for insomnia with the symptoms of sleeplessness, frequent dreams during sleep, palpitation, lassitude, forgetfulness,…

thaipr.net

8 ก.ย. 64

Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer

Today, Jubilant Biosys Limited announced the appointment of Giuliano Perfetti as its Chief Executive Officer. Mr. Perfetti has more than 20 years of experience across diverse businesses and global markets with expertise in Strategy, Sales, Marketing and Business Development. He has led business transformation and expansion programs working in reputed names including Accenture and Astrazeneca among […]

thaipr.net

8 ก.ย. 64
1 98 99 100 101 102 128